Resources
Share
LNP Scale-Up Readiness Checklist
Scaling lipid nanoparticles (LNPs) from bench-scale development to clinically relevant production requires careful consideration of formulation stability, analytical methods, downstream processing, and manufacturing readiness.
Download this practical checklist to explore 15 key questions that can help identify potential scale-up risks, assess LNP development readiness, and support a smoother transition toward clinical manufacturing.